Negative transcriptional regulation of the interferon-γ promoter by glucocorticoids and dominant negative mutants of c-Jun

M. Cippitelli, A. Sica, V. Viggiano, J. Ye, P. Ghosh, M. J. Birrer, H. A. Young

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Interferon-γ (IFN-γ) is an immunoregulatory cytokine expressed in large granular lymphocytes and T cells. However, the molecular mechanisms underlying IFN-γ gene transcription have not been fully defined. Here, we analyze the mechanisms responsible for the inhibition of IFN-γ promoter activity by the glucocorticoid hormone dexamethasone. Cotransfection assays performed in Jurkat T cells demonstrated that the activity of the initial 108 base pairs of the IFN-γ promoter was downregulated in the presence of dexamethasone. Furthermore, utilizing electrophoretic mobility shift analysis, we identified activator protein 1 AP-1-cAMP response element binding protein-activating transcription factor (CREB-ATF) binding elements situated in positions of the IFN-γ promoter previously identified as essential for promoter activity. Moreover, dominant negative mutants of the c-Jun proto-oncogene were able to mimic the same down-regulatory effect exerted by dexamethasone, and mutations that abolished the binding of the AP- 1·CREB-ATF factors were able to block the glucocorticoid effect. These results suggest a model involving the inhibition of IFN-γ AP-1·CREB-ATF DNA binding complexes as one of the mechanisms involved in the negative regulatory action of glucocorticoids on IFN-γ gene expression and support the relevance of AP-1·CREB-ATF binding factors during the transcriptional activation of the IFN-γ promoter in T cells.

Original languageEnglish
Pages (from-to)12548-12556
Number of pages9
JournalJournal of Biological Chemistry
Volume270
Issue number21
DOIs
Publication statusPublished - 1995

Fingerprint

Interferons
Glucocorticoids
T-cells
Dexamethasone
Transcription Factor AP-1
T-Lymphocytes
Activating Transcription Factors
jun Genes
Cyclic AMP Response Element-Binding Protein
Electrophoretic mobility
Jurkat Cells
Lymphocytes
Transcription
Gene expression
Base Pairing
Transcriptional Activation
Assays
Down-Regulation
Genes
Chemical activation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Negative transcriptional regulation of the interferon-γ promoter by glucocorticoids and dominant negative mutants of c-Jun. / Cippitelli, M.; Sica, A.; Viggiano, V.; Ye, J.; Ghosh, P.; Birrer, M. J.; Young, H. A.

In: Journal of Biological Chemistry, Vol. 270, No. 21, 1995, p. 12548-12556.

Research output: Contribution to journalArticle

Cippitelli, M. ; Sica, A. ; Viggiano, V. ; Ye, J. ; Ghosh, P. ; Birrer, M. J. ; Young, H. A. / Negative transcriptional regulation of the interferon-γ promoter by glucocorticoids and dominant negative mutants of c-Jun. In: Journal of Biological Chemistry. 1995 ; Vol. 270, No. 21. pp. 12548-12556.
@article{de8022bf9508464e814dc27b450af2fd,
title = "Negative transcriptional regulation of the interferon-γ promoter by glucocorticoids and dominant negative mutants of c-Jun",
abstract = "Interferon-γ (IFN-γ) is an immunoregulatory cytokine expressed in large granular lymphocytes and T cells. However, the molecular mechanisms underlying IFN-γ gene transcription have not been fully defined. Here, we analyze the mechanisms responsible for the inhibition of IFN-γ promoter activity by the glucocorticoid hormone dexamethasone. Cotransfection assays performed in Jurkat T cells demonstrated that the activity of the initial 108 base pairs of the IFN-γ promoter was downregulated in the presence of dexamethasone. Furthermore, utilizing electrophoretic mobility shift analysis, we identified activator protein 1 AP-1-cAMP response element binding protein-activating transcription factor (CREB-ATF) binding elements situated in positions of the IFN-γ promoter previously identified as essential for promoter activity. Moreover, dominant negative mutants of the c-Jun proto-oncogene were able to mimic the same down-regulatory effect exerted by dexamethasone, and mutations that abolished the binding of the AP- 1·CREB-ATF factors were able to block the glucocorticoid effect. These results suggest a model involving the inhibition of IFN-γ AP-1·CREB-ATF DNA binding complexes as one of the mechanisms involved in the negative regulatory action of glucocorticoids on IFN-γ gene expression and support the relevance of AP-1·CREB-ATF binding factors during the transcriptional activation of the IFN-γ promoter in T cells.",
author = "M. Cippitelli and A. Sica and V. Viggiano and J. Ye and P. Ghosh and Birrer, {M. J.} and Young, {H. A.}",
year = "1995",
doi = "10.1074/jbc.270.21.12548",
language = "English",
volume = "270",
pages = "12548--12556",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "21",

}

TY - JOUR

T1 - Negative transcriptional regulation of the interferon-γ promoter by glucocorticoids and dominant negative mutants of c-Jun

AU - Cippitelli, M.

AU - Sica, A.

AU - Viggiano, V.

AU - Ye, J.

AU - Ghosh, P.

AU - Birrer, M. J.

AU - Young, H. A.

PY - 1995

Y1 - 1995

N2 - Interferon-γ (IFN-γ) is an immunoregulatory cytokine expressed in large granular lymphocytes and T cells. However, the molecular mechanisms underlying IFN-γ gene transcription have not been fully defined. Here, we analyze the mechanisms responsible for the inhibition of IFN-γ promoter activity by the glucocorticoid hormone dexamethasone. Cotransfection assays performed in Jurkat T cells demonstrated that the activity of the initial 108 base pairs of the IFN-γ promoter was downregulated in the presence of dexamethasone. Furthermore, utilizing electrophoretic mobility shift analysis, we identified activator protein 1 AP-1-cAMP response element binding protein-activating transcription factor (CREB-ATF) binding elements situated in positions of the IFN-γ promoter previously identified as essential for promoter activity. Moreover, dominant negative mutants of the c-Jun proto-oncogene were able to mimic the same down-regulatory effect exerted by dexamethasone, and mutations that abolished the binding of the AP- 1·CREB-ATF factors were able to block the glucocorticoid effect. These results suggest a model involving the inhibition of IFN-γ AP-1·CREB-ATF DNA binding complexes as one of the mechanisms involved in the negative regulatory action of glucocorticoids on IFN-γ gene expression and support the relevance of AP-1·CREB-ATF binding factors during the transcriptional activation of the IFN-γ promoter in T cells.

AB - Interferon-γ (IFN-γ) is an immunoregulatory cytokine expressed in large granular lymphocytes and T cells. However, the molecular mechanisms underlying IFN-γ gene transcription have not been fully defined. Here, we analyze the mechanisms responsible for the inhibition of IFN-γ promoter activity by the glucocorticoid hormone dexamethasone. Cotransfection assays performed in Jurkat T cells demonstrated that the activity of the initial 108 base pairs of the IFN-γ promoter was downregulated in the presence of dexamethasone. Furthermore, utilizing electrophoretic mobility shift analysis, we identified activator protein 1 AP-1-cAMP response element binding protein-activating transcription factor (CREB-ATF) binding elements situated in positions of the IFN-γ promoter previously identified as essential for promoter activity. Moreover, dominant negative mutants of the c-Jun proto-oncogene were able to mimic the same down-regulatory effect exerted by dexamethasone, and mutations that abolished the binding of the AP- 1·CREB-ATF factors were able to block the glucocorticoid effect. These results suggest a model involving the inhibition of IFN-γ AP-1·CREB-ATF DNA binding complexes as one of the mechanisms involved in the negative regulatory action of glucocorticoids on IFN-γ gene expression and support the relevance of AP-1·CREB-ATF binding factors during the transcriptional activation of the IFN-γ promoter in T cells.

UR - http://www.scopus.com/inward/record.url?scp=0029052324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029052324&partnerID=8YFLogxK

U2 - 10.1074/jbc.270.21.12548

DO - 10.1074/jbc.270.21.12548

M3 - Article

C2 - 7759501

AN - SCOPUS:0029052324

VL - 270

SP - 12548

EP - 12556

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 21

ER -